As an example, antibodies against TNF were tested as potential anti-inflammatory therapies in human alcoholic hepatitis but some studies were terminated due to adverse outcomes (Blendis and Dotan, 2004) or showed no mortality benefit over standard therapies. The gene discussed is TNF; the disease is alcoholic hepatitis.